Sign up to gain complete access to Medznat
Please verify that you are a Healthcare Professional. Register for complete access to all the content!
Role of preemptive intravenous ibuprofen in laparoscopic cholecys...
A single 400-mg preemptive intravenous dose of ibuprofen improves postoperative analgesia, prolongs time to first rescue analgesia, and reduces t...
Nortriptyline-based strategies for episodic migraine prevention
Combination preventive therapy delivers a greater reduction in monthly headache days and better treatment adherence than nortriptyline monotherap...
Cardiometabolic risk reduction with oral semaglutide in high-risk...
Oral semaglutide improves multiple cardiometabolic risk factors, with benefits emerging early and persisting during long-term treatment.
Standardized Ferula extract for menopausal symptoms: Findings fro...
Three months of daily standardized Ferula extract supplementation (20 mg) improves menopausal symptoms, reduces oxidative stress and fat mass, an...
Efficacy of mesotherapy vs. oral combination therapy in acute and...
Intradermal mesotherapy significantly reduces pain and neck-related disability, with outcomes comparable to oral meloxicam + thiocolchicoside ove...
Myo-inositol and reproductive outcomes in PCOS: A prospective int...
Twelve weeks of myo-inositol supplementation improves ovulation, menstrual regularity, and selected hormonal parameters in PCOS.
Understanding gastrointestinal anxiety in inflammatory bowel dise...
Gastrointestinal-specific anxiety in inflammatory bowel disease is driven primarily by systemic psychological distress rather than local inflamma...
Semaglutide vs. tirzepatide in non-diabetic obesity: Real-world c...
In people with overweight or obesity, established ASCVD, and no diabetes, using semaglutide is linked with lower risks of major adverse cardiovas...
Predictors of topical antifungal failure in onychomycosis
During topical antifungal therapy for onychomycosis, great toenail involvement and increased nail thickness are associated with poorer response a...
Oral semaglutide and heart failure: Evidence from the SOUL random...
Oral semaglutide minimizes the risk of composite heart failure outcomes in those with type 2 diabetes and pre-existing heart failure, particularl...
Nocturnal GERD and sleep disruption: Systematic review highlights...
Proton pump inhibitor (PPI) therapy reduces nighttime heartburn and gastroesophageal reflux disease (GERD)–related sleep disturbances witho...
ERAS-SBI pathway in total knee arthroplasty: Optimising recovery...
An ERAS pathway integrated with the safe brain initiative shortens hospitalisation, reduces early rescue opioid requirements, and supports more e...
This website uses cookies to help us give you the best experience when you visit.
By using this website you consent to our use of cookies. For more information please review our cookie policy.
